The Readout Loud

331 Episodes

1. Episode 50: A big scoop on opioid marketing

   Published: 22/02/2019
2. Episode 49: Painkiller racketeering, the limits of genetic tests, and pharma's day on the Hill

   Published: 21/02/2019
3. Episode 48: The AI hype machine, ketamine's future, and the rocky path ahead for NASH

   Published: 14/02/2019
4. Episode 47: A bad day for bold biotech, campaign 2020, and where do drugs come from?

   Published: 07/02/2019
5. Episode 46: Another Alzheimer's setback, crypto for biotech, and a blessing of unicorns

   Published: 31/01/2019
6. Episode 45: CRISPR upheaval, Celgene's chutzpah, and canine genomics

   Published: 24/01/2019
7. Episode 44: FDA furloughs, '80s pop radio, and video game therapeutics

   Published: 17/01/2019
8. Episode 43: A people's history of J.P. Morgan

   Published: 10/01/2019
9. Episode 42: Parsing Bristol-Myers-Celgene, grousing about JPM, and how to not be boring

   Published: 03/01/2019
10. Episode 41: Watson's latest stumble, a glimpse into the crystal ball, and revisiting Sarepta

    Published: 20/12/2018
11. Episode 40: Gilead’s new boss, the year that was, and the thing about DNA tests

    Published: 13/12/2018
12. Episode 39: Using the word 'cure,' an FDA loophole, & making biotech history

    Published: 06/12/2018
13. Episode 38: Your guide to the #CRISPRbabies controversy

    Published: 29/11/2018
14. Episode 37: The biggest-ever IPO, drug prices rising in tandem, and burner Twitter accounts

    Published: 15/11/2018
15. Episode 36: What the midterms mean, a golden age on hold, and the $4 million drug

    Published: 08/11/2018
16. Episode 35: Biotech's October slump, the precise cost of precision, and breaking postpartum silence

    Published: 01/11/2018
17. Episode 34: Pharma at the ballot box, the latest Alzheimer's argument, and a rare disease dilemma

    Published: 25/10/2018
18. Episode 33: Drug prices on TV, immortal blockbusters, and genetic privacy

    Published: 18/10/2018
19. Episode 32: Fake friends at the FDA, cancer counter-narratives, and biotech's bear turn

    Published: 11/10/2018
20. Episode 31: Nobel snubs, millenial founders, and a new kind of lightning round

    Published: 04/10/2018